It is thus evident that the genetic background of our AD patients impacts their neuronal phenotypes, and other AD-related SNPs might contribute to differences in cellular phenotypes, providing additional AD risk or protective factors besides the presence of PSEN1 mutations. This evidence concerns the gene PSEN1 and Alzheimer disease.